5 Best Pharmaceutical Stocks to Buy According to Billionaire Joseph Edelman

Page 5 of 5

1. Collegium Pharmaceutical, Inc. (NASDAQ: COLL)

Edelman’s Stake Value: $23,185,000
Percentage of Joseph Edelman’s 13F Portfolio: 0.29%
Number of Hedge Fund Holders: 15

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) is a pharma company, which develops and commercializes medicines to control pain. The company was founded in 2002 and is ranked first on the list of 10 best pharmaceutical stocks to buy according to billionaire Joseph Edelman. Collegium shares have gained about 33.15% in value over the last 12 months. 

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) posted earnings for the first quarter of 2021 on May 6, reporting earnings per share of $0.41, beating market predictions by $0.11. The revenue for the first three months of 2021 was $87.72 million, up 14.7% YoY, beating the estimates by $6.09 million. The company raised its FY 2021 adjusted EBITDA guidance to $170.0 to $180.0 million from $160.0 to $170.0 million. 

As of Q1 2021, 15 hedge funds in Insider Monkey’s database of 887 funds held stakes in Collegium Pharmaceutical, Inc. (NASDAQ: COLL), compared to 20 funds in Q4 2020.

You can also take a peek at 10 Best Pharmaceutical Stocks to Buy According to Cathie Wood and Top 15 Pharmaceutical Companies With Highest R&D Spending. 

Page 5 of 5